4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity

NAActive, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 28, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Breast Cancer
Interventions
BEHAVIORAL

Weight Loss

Participants are instructed to perform a modified fast (\~500 kcal) on 3 days/week with ad libitum intake the other 4 days/week. Group-based behavioral support sessions will be held by an experienced Registered Dietician. Participants will attend BfitBwell exercise sessions in person and virtually to receive individualized support to progress to 150 min/wk of moderate-intensity physical activity

Trial Locations (2)

80045

Anschutz Health and Wellness, Aurora

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER

NCT06399276 - 4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity | Biotech Hunter | Biotech Hunter